Mary K. Moreland - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Mary K. Moreland by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
28 Feb 2023
Net transactions value
-$663,489
Form type
4
Filing time
02 Mar 2023, 18:45:37 UTC
Previous filing
22 Feb 2023
Next filing
23 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability $591,237 -5,926 -6.3% $99.77 87,941 28 Feb 2023 Direct
transaction ABT Common shares without par value Sale $72,252 -717 -0.82% $100.77 87,224 01 Mar 2023 Direct
holding ABT Common shares without par value 11,180 28 Feb 2023 Profit Sharing Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).